The Ministry of Health authorized this Friday (27) the application of the third dose of the vaccine against Covid-19 in adolescents aged 12 to 17 years. Until then, the booster was released only for immunosuppressed young people and people aged 18 or over.
The third dose should be given four months after the second dose, preferably with the Pfizer vaccine. In a technical note, the folder states, however, that, in the absence of the immunizer for “logistical or access reasons”, the booster can be done with Coronavac, produced by the Butantan Institute.
The scheme will be the same for pregnant or postpartum adolescents. The only exception is for immunocompromised teens, who can only receive the Pfizer vaccine — and have been vaccinated since February.​
Despite authorization from the ministry, states and municipalities have the autonomy to define the start of the third dose in the new target audience.
The recommendation for the third dose in teenagers had been made two weeks ago by the technical chamber that advises the ministry.
In the technical note, the folder considered that the epidemiological scenario is still uncertain and that scientific evidence demonstrates the “reduced protective response of the 2-dose regimen for the Ômicron variant” in the group aged 12 to 17 years.
The document was signed this Friday night by the extraordinary secretary for the fight against Covid, Rosana Leite de Melo, and by the director of the program of the Extraordinary Secretary for the fight against Covid, Danilo de Souza Vasconcelos.
Chad-98Weaver, a distinguished author at NewsBulletin247, excels in the craft of article writing. With a keen eye for detail and a penchant for storytelling, Chad delivers informative and engaging content that resonates with readers across various subjects. His contributions are a testament to his dedication and expertise in the field of journalism.
